Evolus (EOLS) Other Operating Expenses (2017 - 2026)
Evolus' (EOLS) quarterly Other Operating Expenses came in at $14000.0 in Q1 2026, up 100.65% YoY from $6977.3 in Q1 2025, and down 99.69% on a QoQ basis from $4.5 million in Q4 2025.
Evolus (EOLS) Other Operating Expenses (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Other Operating Expenses data on file, last reported at $14000.0 in Q1 2026.
- Quarterly Other Operating Expenses rose 100.65% year-over-year to $14000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (up 210.29% YoY) and the FY2025 annual result came in at $6.4 million, up 188.92% from the prior year.
- Other Operating Expenses eased to $14000.0 in Q1 2026, from $4.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $4.5 million in Q4 2025 to a low of -$2.4 million in Q3 2024.
- A 5-year average of -$634882.4 and a median of -$1.6 million in 2024 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses tumbled 278.86% — and 2025, when it soared 388.24%.
- Tracing EOLS's Other Operating Expenses over 5 years: stood at -$1.8 million in 2022, then soared by 148.37% to $875000.0 in 2023, then plunged by 278.86% to -$1.6 million in 2024, then soared by 388.24% to $4.5 million in 2025, then sank by 99.69% to $14000.0 in 2026.
- The last three Other Operating Expenses figures came in at $14000.0 (Q1 2026), $4.5 million (Q4 2025), and $107000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Evolus | 553.80 Mn | 508.63 Mn | 57.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.25 Mn |
| Mar 31, 2026 | 14,000.00 |
| Dec 31, 2025 | 4.51 Mn |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | -2.15 Mn |
| Dec 31, 2024 | -1.57 Mn |
| Sep 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | -1.61 Mn |
| Mar 31, 2024 | -1.58 Mn |
| Dec 31, 2023 | 875,000.00 |
| Sep 30, 2023 | -1.80 Mn |
| Jun 30, 2023 | -1.68 Mn |
| Mar 31, 2023 | -1.65 Mn |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -1.41 Mn |
| Mar 31, 2022 | -1.32 Mn |
| Dec 31, 2021 | 29.55 Mn |
| Jun 30, 2021 | -1.38 Mn |